South Asian Women & Yoga Education Study (SAWYES)

November 16, 2012 updated by: Dr. Amandah Hoogbruin, Kwantlen Polytechnic University

Yoga for Post-menopausal South Asian Women at Risk for Cardiovascular Disease: A Randomized Control Pilot Study

The purpose of this randomized, control pilot study is to measure the effects of a gentle, 12 week hatha yoga program on post-menopausal, obese, sedentary South Asian women at risk for cardiovascular disease. Hatha yoga is a form of structured physical exercises known as asanas, combined with breathing exercises called pranayama, and relaxation techniques. The yoga intervention consists of 9 different yoga poses (asanas) and 3 different breathing exercises (pranayama) that can be easily replicated and readily performed by individuals who are middle-aged and older, overweight, unfit, or who suffer from a chronic illness.

Study Overview

Status

Unknown

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

50

Phase

  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • British Columbia
      • Surrey, British Columbia, Canada, V3T 0G9
        • Recruiting
        • The Jim Pattison Outpatient Care and Surgery Services, Cardiovascular Outpatient Clinic
        • Contact:
        • Contact:
      • Surrey, British Columbia, Canada, V3W 2M8
        • Not yet recruiting
        • Kwantlen Polytechnic University
        • Contact:
        • Contact:
        • Principal Investigator:
          • Amandah L Hoogbruin, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • 40- 65 years old
  • Postmenopausal (amenorrhea for ≥ 12 months)
  • Overweight as evidenced by a body mass index (BMI) ≥ 25 kg/m2), or waist circumference ≥ 80 cm, or have a first degree relative with diabetes or essential hypertension
  • Sedentary, do not do a regular exercise program (exercising for 20 minutes at sufficient intensity to produce sweating less than 2x/week)
  • Self-identify as a South Asian (sometimes referred to as East Indian in Canada and may be defined "as any person who reports an ethnicity associated with the southern part of Asia or who self-identifies as part of the South Asian visible minority group. This definition encompasses people from a great diversity of ethnic backgrounds, including those with Bangladeshi, Bengali, East Indian, Goan, Gujarati, Hindu, Ismaili, Kashmiri, Nepali, Pakistani, Punjabi, Sikh, Sinhalese, South Asian, Sri Lankan and Tamil ancestry. South Asians may have been born in Canada, on the Indian sub-continent, in the Caribbean, in Africa, in Great Britain or elsewhere
  • Given consent to research protocol and willingness to be randomized to either the treatment (yoga) or control (no yoga) group.

Exclusion Criteria:

  • Have had a period within the last year
  • Are not between the ages of 40 and 65
  • Have experience with yoga within the last 12 months
  • Have any serious disease or condition such as diabetes, serious high blood pressure or heart problems, kidney disease, severe asthma, cancer (except for skin cancer that is not melanoma)
  • Have a major brain or nervous system diagnosis, such as Parkinson's disease or stroke
  • Have a severe infectious or other medical illness right now such as pneumonia
  • Use medications to lower blood sugar levels
  • Have serious back, hip, or neck problems or pain in joints or bones that would prevent the safe completion of a gentle 12 week Hatha yoga program
  • Regularly use an assistive device (e.g., cane, walker) to walk

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
Experimental: Yoga Intervention
12 week 90 minute hatha yoga session offered three (3x) per week. Hatha yoga is a form of structured physical exercises known as asanas, combined with breathing exercises called pranayama, and relaxation techniques. The yoga intervention consists of 9 different yoga poses (asanas) and 3 different breathing exercises (pranayama) that can be easily replicated and readily performed by individuals who are middle-aged and older, overweight, unfit, or who suffer from a chronic illness.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in blood pressure
Time Frame: baseline, at end of study (12 wks), & 3 months post-study
blood pressure is measured as a specific physiologic index of cardiovascular risk.
baseline, at end of study (12 wks), & 3 months post-study

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in subjective well-being
Time Frame: baseline, at end of study (12 wks), & 3 months post-study
The Perceived Stress Scale and Abbreviated Duke Social Support Index will be used to measure subjective well-being.
baseline, at end of study (12 wks), & 3 months post-study
Change in perceived physical well-being
Time Frame: baseline, end of study (12 wks) & 3 months post-study
Pittsburgh Sleep Quality Index, Physical Activity Scale for the Elderly, and Exercise Regularly Scale will be used to measure change in perceived physical well-being
baseline, end of study (12 wks) & 3 months post-study
Change in insulin sensitivity
Time Frame: baseline, end of study (12 wks) & 3 months post-study
Fasting insulin & glucose will be measured for change in insulin sensitivity as a related index of cardiovascular risk
baseline, end of study (12 wks) & 3 months post-study
Change in inflammation
Time Frame: baseline, end of study (12 wks) & 3 months post-study
C-reactive protein will be measured for change in inflammation as a related index of cardiovascular risk
baseline, end of study (12 wks) & 3 months post-study
Change in serum total cholesterol
Time Frame: baseline, end of study (12 wks) & 3 months post-study
Serum total cholesterol will be measured as a related index of cardiovascular risk
baseline, end of study (12 wks) & 3 months post-study
Change in serum high-density lipoprotein (HDL) cholesterol
Time Frame: baseline, end of study (12 wks) & 3 months post-study
Serum high-density lipoprotein (HDL) cholesterol will be measured as a related index of cardiovascular risk
baseline, end of study (12 wks) & 3 months post-study
Change in serum low-density lipoprotein (LDL) cholesterol
Time Frame: baseline, end of study (12 wks) & 3 months post-study
Serum low-density lipoprotein (LDL)cholesterol will be measured as a related index of cardiovascular risk
baseline, end of study (12 wks) & 3 months post-study
Change in serum triglycerides
Time Frame: baseline, end of study (12 wks) & 3 months post-study
Serum triglycerides will be measured as a related index of cardiovascular risk
baseline, end of study (12 wks) & 3 months post-study
Change in waist circumference.
Time Frame: baseline, end of study (12 wks) & 3 months post-study
Waist circumference will be measured for change in visceral adiposity as a related index of cardiovascular risk
baseline, end of study (12 wks) & 3 months post-study
Change waist-hip ratio
Time Frame: baseline, end of study (12 wks) & 3 months post-study
Waist-hip ratio will be measured for change in visceral adiposity as a related index of cardiovascular risk
baseline, end of study (12 wks) & 3 months post-study
Change in body mass index (BMI)
Time Frame: baseline, end of study (12 wks) & 3 months post-study
Body mass index (BMI) will be measured for change in visceral adiposity as a related index of cardiovascular risk
baseline, end of study (12 wks) & 3 months post-study
Change in resting heart rate
Time Frame: baseline, end of study (12 wks) & 3 months post-study
Resting heart rate will be measured for change in sympathetic activity as a related index of cardiovascular risk
baseline, end of study (12 wks) & 3 months post-study
Change in heart rate
Time Frame: baseline, at end of study (12 wks), & 3 months post-study
Heart rate will be measured for change in sympathetic activity as a related index of cardiovascular risk
baseline, at end of study (12 wks), & 3 months post-study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Amandah L Hoogbruin, PhD, Kwantlen Polytechnic University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2012

Primary Completion (Anticipated)

December 1, 2014

Study Completion (Anticipated)

August 1, 2015

Study Registration Dates

First Submitted

June 17, 2012

First Submitted That Met QC Criteria

August 14, 2012

First Posted (Estimate)

August 17, 2012

Study Record Updates

Last Update Posted (Estimate)

November 19, 2012

Last Update Submitted That Met QC Criteria

November 16, 2012

Last Verified

November 1, 2012

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • KK11-04

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Disease

Clinical Trials on Yoga Intervention

Subscribe